AGIOS PHARMACEUTICALS, INC. (AGIO) has 18 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $914K. Most recent filing: Aug. 6, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Aug. 6, 2026 filed Aug. 4, 2026 | Gheuens Sarah Chief Medical Officer | −$914,400 | 30,000 | −35% | Yes | |
|
|
||||||
| July 10, 2026 filed July 8, 2026 | Backstrom Jay T. Director | $0 | 2,894 | +100% | No | |
|
|
||||||
| July 2, 2026 filed July 1, 2026 | Gheuens Sarah Chief Medical Officer | — | +4,368 | — | Yes | |
|
|
||||||
| June 23, 2026 filed June 18, 2026 | Ballal Rahul D. Director | $0 | 23,509 | +23% | No | |
|
|
||||||
| June 23, 2026 filed June 18, 2026 | Foster-Cheek Kaye I Director | $0 | 23,509 | +23% | No | |
|
|
||||||
Showing the 5 most recent of 18 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free